Atlas Trials

Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose

Clinical trial NCT01300260 · COMPLETED

Trial details

NCT number
NCT01300260
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2011-02-01
Primary completion
2011-08-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.